Can autoantibody tests enhance lung cancer screening?—an evaluation of EarlyCDT(®)-Lung in context of the German Lung Cancer Screening Intervention Trial (LUSI)

類似資料

• Validation of multivariable lung cancer risk prediction models for the personalized assignment of optimal screening frequency: a retrospective analysis of data from the German Lung Cancer Screening Intervention Trial (LUSI)
  著者:: González Maldonado, Sandra, 等
  出版事項: (2021)
• EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
  著者:: Chapman, Caroline J., 等
  出版事項: (2012)
• Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.
  著者:: John Edelsberg, 等
  出版事項: (2018-01-01)
• Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules
  著者:: Edelsberg, John, 等
  出版事項: (2018)
• Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial
  著者:: Sullivan, F. M., 等
  出版事項: (2017)